PROS1 and COVID-19: The presence of soluble S protein after vaccination with the BNT162b2 (BioNTech) vaccine was recently shown in plasma in humans [39,43] and in mice [40,44] and has been associated with the occurrence of myocarditis in young male patients dosed with the mRNA-based COVID-19 vaccine [43,45].